
Timing is key in reducing the risk of developing vision loss or blindness.
Timing is key in reducing the risk of developing vision loss or blindness.
Test your knowledge!
Expected findings in follow-up, management, and potential complications.
Expand your business by administering injectable treatments.
A review of monitoring guidelines, risk assessment, and treatment algorithms.
Current findings review risks, benefits, and performance.
With its anti-infective, anti-inflammatory, and regenerative properties, this versatile therapeutic should be in your toolbox.
A 68-year-old White woman was referred for persistent keratitis OS and failure on multiple medications. Find out her official diagnosis and treatment plan.